Industry Trends & Resources

Global Clinical Trial Support: Connecting Across Borders

Global Clinical Trial Support: Connecting Across Borders

Connecting Patients, Sites and Study Teams Across Borders Clinical trials are becoming increasingly global. Patients may travel across cities, states, or even international borders to access specialized treatments and participate in studies. While expanding a trial geographically can help sponsors reach more diverse patient populations, it also introduces another layer

Read More »
Плащания и възстановявания на пациенти

По-интелигентен подход към плащанията и възстановяването на разходи на пациенти

Patient Payments and Reimbursements Clinical trial participation can require a significant investment of time, travel, and personal resources from patients and their caregivers. Even when a study offers an important opportunity to access new treatments or advance medical research, out-of-pocket expenses can create an additional barrier to participation. Travel costs,

Read More »
Навигиране в оперативната реалност на онкологичните клинични изпитвания: Защо дизайнът на пътуванията и разходите е от значение за възложителите

Навигиране в оперативната реалност на онкологичните клинични изпитвания

Navigating the Operational Reality of Oncology Trials: Why Travel & Expense Design Matters to Sponsors Oncology clinical trials are designed around scientific rigor, regulatory precision, and the promise of advancing care. But beneath the protocol design and endpoints sits a quieter determinant of success: whether participants can realistically stay engaged

Read More »
Месец за повишаване на осведомеността за саркома: Напредък на надеждата чрез изследвания

Месец за повишаване на осведомеността за саркома: Напредък на надеждата чрез изследвания

Sarcoma Awareness Month: Advancing Hope Through Research, Collaboration, and Clinical Trials Every July, Sarcoma Awareness Month brings attention to one of the rarest and most diverse forms of cancer while recognizing the patients, families, clinicians, researchers, and advocates dedicated to improving outcomes. Sarcomas account for approximately 1% of adult cancers

Read More »
Преминаване към съдържанието